Want to join the conversation?
$BSX,which competes with rivals $MDT, $ABT and $JNJ, said that pacemaker sales grew 3% globally aided by the recently launched X4 CRT-P core device, while worldwide ICD sales fell 4%. The EMBLEM S-ICD is showing strong growth in Europe and US and is currently launching in Japan. Electrophysiology had double-digit growth in Europe.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?